MedTrace Logo

A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon

NCT01285271 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-10-06

No results posted yet for this study

Summary

The aim of this study is to determine whether xenon - as compared to sevoflurane - can be applied safely in patients for general anesthesia before and after CABG implantation.

Conditions

  • Xenon
  • Sevoflurane
  • Anesthetics, Inhalation
  • Coronary Disease
  • Coronary Artery Bypass

Interventions

DRUG

Xenon

gaseous anesthetic, dosage: 50% (v/v) in 50% oxygen, continuous application before the start and after the end of extracorporal circulation

DRUG

Sevoflurane

inhalative anesthetic, dosage: 1.4% (v/v) in 50% oxygen/medical air , continuous application before the start and after the end of extracorporal circulation

Sponsors & Collaborators

  • German Research Foundation

    collaborator OTHER

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Mark Coburn, PD Dr. med. · Department of Anesthesiology, University Hospital Aachen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01285271 on ClinicalTrials.gov